Kadmon Holdings PE Ratio 2015-2021 | KDMN

Current and historical p/e ratio for Kadmon Holdings (KDMN) from 2015 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Kadmon Holdings PE ratio as of September 23, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Kadmon Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-09-23 8.89 0.00
2021-06-30 3.87 $-0.67 0.00
2021-03-31 3.89 $-0.66 0.00
2020-12-31 4.15 $-0.68 0.00
2020-09-30 3.92 $-0.60 0.00
2020-06-30 5.12 $-0.94 0.00
2020-03-31 4.19 $-0.70 0.00
2019-12-31 4.53 $-0.49 0.00
2019-09-30 2.52 $-0.77 0.00
2019-06-30 2.06 $-0.41 0.00
2019-03-31 2.64 $-0.24 0.00
2018-12-31 2.08 $-0.53 0.00
2018-09-30 3.34 $-0.40 0.00
2018-06-30 3.99 $-0.69 0.00
2018-03-31 4.25 $-1.37 0.00
2017-12-31 3.62 $-1.49 0.00
2017-09-30 3.35 $-1.75 0.00
2017-06-30 3.89 $-5.56 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.527B $0.008B
Kadmon Holdings Inc. is a biopharmaceutical company. It discovers, develops and delivers transformative therapies for unmet medical needs. The company's product pipeline includes KD025, KD045 and KD033 which are in clinical satge. Kadmon Holdings Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71